Editorial: Mechanism and therapeutic potential of macrophages in metabolic and cardiovascular diseases

被引：0
|
作者：
Nie, Xuqiang [1 ,2 ,3 ]
Deng, Youcai [4 ]
Tong, Xiaoyong [5 ]
Han, Felicity [6 ]
机构：
[1] Zunyi Med Univ, Coll Pharm, Zunyi, Guizhou, Peoples R China
[2] Zunyi Med Univ, Joint Int Res Lab Ethnomed, Minist Educ, Zunyi, Guizhou, Peoples R China
[3] Zunyi Med Univ, Key Lab Basic Pharmacol, Minist Educ, Zunyi, Guizhou, Peoples R China
[4] Army Med Univ, Coll Pharm & Lab Med Sci, Dept Clin Hematol, Chongqing, Peoples R China
[5] Chongqing Univ, Sch Pharmaceut Sci, Chongqing, Peoples R China
[6] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia
来源：
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
基金：
中国国家自然科学基金;
关键词：
macrophages; cardiovascular diseases; atherosclerosis; metabolic diseases; therapeutic potential; diabetic nephropathy; GBP2;
D O I：
10.3389/fimmu.2023.1352567
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Editorial: Natural products targeting oxidative stress and cell death: Treatment potential in metabolic and cardiovascular diseases
    Kosuru, Ramoji
    Cai, Yin
    Tiwari, Vinod
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [22] Osteocalcin as a potential risk biomarker for cardiovascular and metabolic diseases
    Magni, Paolo
    Macchi, Chiara
    Sirtori, Cesare R.
    Romanelli, Massimiliano Marco Corsi
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2016, 54 (10) : 1579 - 1587
  • [23] Therapeutic potential of cannabidiol (CBD) in the treatment of cardiovascular diseases
    Naya, Nadia Martinez
    Kelly, Jazmin
    Hogwood, Austin
    Abbate, Antonio
    Toldo, Stefano
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2024, 33 (07) : 699 - 712
  • [24] Metrnl: a promising biomarker and therapeutic target for cardiovascular and metabolic diseases
    Dong, Wen-sheng
    Hu, Can
    Hu, Min
    Gao, Yi-peng
    Hu, Yu-xin
    Li, Kang
    Ye, Yun-jia
    Zhang, Xin
    CELL COMMUNICATION AND SIGNALING, 2024, 22 (01)
  • [25] Therapeutic Potential of Chymase Inhibitors in Cardiovascular Diseases: An Overview
    Aga, Qutaiba Ahmed Al Khames
    Nair, Anroop B.
    Hourani, Wafa
    Parasuraman, Subramani
    Ahmed, Mueen K. K.
    Sreeharsha, Nagaraja
    INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2020, 54 (03) : 509 - 516
  • [26] The therapeutic potential of mesenchymal stem cells for cardiovascular diseases
    Guo, Yajun
    Yu, Yunsheng
    Hu, Shijun
    Chen, Yueqiu
    Shen, Zhenya
    CELL DEATH & DISEASE, 2020, 11 (05)
  • [27] Leukotrienes: potential therapeutic targets in cardiovascular diseases - Discussion
    Vacheron, M. Andre
    Godeau, M. Pierre
    Michel, M. Francis-Bernard
    de Gennes, M. Jean-Luc
    Queneau, M. Patrice
    Ardaillou, M. Raymond
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2006, 190 (07): : 1518 - 1521
  • [28] Sirtuin 6: A potential therapeutic target for cardiovascular diseases
    Xie Saiyang
    Deng Wei
    Tang Qizhu
    PHARMACOLOGICAL RESEARCH, 2021, 163
  • [29] RNA modifications in cardiovascular diseases, the potential therapeutic targets
    Wu, Yirong
    Zhan, Siyao
    Xu, Yizhou
    Gao, Xiangwei
    LIFE SCIENCES, 2021, 278
  • [30] The therapeutic potential of mesenchymal stem cells for cardiovascular diseases
    Yajun Guo
    Yunsheng Yu
    Shijun Hu
    Yueqiu Chen
    Zhenya Shen
    Cell Death & Disease, 11
12345